MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,404,640 | +0.1% | 216,000 | -16.9% | 3.17% | +10.8% |
| Q2 2023 | $9,393,800 | +3.5% | 260,000 | +6.6% | 2.86% | +13.0% |
| Q1 2023 | $9,071,920 | -17.9% | 244,000 | 0.0% | 2.53% | -25.9% |
| Q4 2022 | $11,055,640 | +16.4% | 244,000 | +79.4% | 3.42% | +12.1% |
| Q3 2022 | $9,498,000 | -93.0% | 136,000 | +1389.4% | 3.05% | +114.7% |
| Q2 2022 | $136,000,000 | +9805.3% | 9,131 | -95.2% | 1.42% | +357.7% |
| Q1 2022 | $1,373,000 | -92.6% | 188,500 | +49.0% | 0.31% | -92.5% |
| Q4 2021 | $18,549,000 | +6.5% | 126,500 | +28.4% | 4.13% | -1.6% |
| Q3 2021 | $17,419,000 | +538.1% | 98,500 | +482.8% | 4.20% | +482.7% |
| Q2 2021 | $2,730,000 | -76.3% | 16,900 | -74.9% | 0.72% | -76.4% |
| Q1 2021 | $11,536,000 | -22.1% | 67,400 | 0.0% | 3.05% | -24.5% |
| Q4 2020 | $14,804,000 | +231.8% | 67,400 | +150.6% | 4.04% | +180.8% |
| Q3 2020 | $4,462,000 | -11.3% | 26,900 | -38.7% | 1.44% | -13.9% |
| Q2 2020 | $5,032,000 | +49.1% | 43,900 | 0.0% | 1.67% | +8.8% |
| Q1 2020 | $3,374,000 | -27.1% | 43,900 | +22.3% | 1.54% | -7.8% |
| Q4 2019 | $4,630,000 | +445.3% | 35,900 | +229.4% | 1.67% | +325.5% |
| Q3 2019 | $849,000 | -24.4% | 10,900 | 0.0% | 0.39% | -5.8% |
| Q2 2019 | $1,123,000 | -29.4% | 10,900 | -49.8% | 0.42% | -29.1% |
| Q1 2019 | $1,590,000 | – | 21,700 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |